Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Divests Non-Core OTCs, Realigns Consumer Supply Chain

This article was originally published in The Tan Sheet

Executive Summary

Novartis sells six OTC brands, including Bufferin, to focus resources on core consumer health products. The firm also is realigning its consumer health supply chain, including restructuring its Lincoln, Nebraska, manufacturing plant, where the workforce will be cut 40%.

Advertisement

Related Content

Top OTC Stories 2013: Switch, Consumer Business Divestment Plans
Novartis Seems Close to Consumer Health Sale – Analyst
Novartis OTC Plant Troubled By Quality Failures A Year After Shutdown
Chattem To Revive Rolaids Line Bought From J&J
FDA Pressure Likely In Novartis OTC Plant Shutdown, Recalls
Pfizer's Sturman Succeeds Lil' Drug Store's DeWolf As CHPA Board Chair

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel